Titterton Lewis H jr Insider Trades & Stock Holdings

Director · Anixa Biosciences, Inc. · Latest filing Sep 23, 2026

Titterton Lewis H jr, Director at Anixa Biosciences, Inc. has 1 Form 4 trade on file since Sep 23, 2026. Open-market activity: 1 purchase ($131.91K) and 0 sales ($0), net +$131.91K. Latest filing: acquired 49.04K shares of $ANIX on Sep 23, 2026 at $2.69.

Trades on file

1

Open-market bought

$131.91K

Open-market sold

$0

Net open-market

+$131.91K

Latest filing

Sep 23, 2026

All insider trades by Titterton Lewis H jr

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 23, 2026	$ANIX	Buy (Open-market buy)	49.04K	$2.69	$131.91K			+6.5%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Titterton Lewis H jr traded

• $ANIX

Frequently asked questions

Has Titterton Lewis H jr been buying or selling stock?

Titterton Lewis H jr has 1 open-market purchase and 0 open-market sales on file, net +$131.91K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Titterton Lewis H jr's latest insider trade?

acquired 49.04K shares of $ANIX on Sep 23, 2026 at $2.69.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.